Ada Sanchez

Background

About Ada Sanchez

Orchestrating market development strategies for novel therapies has been the cornerstone of my career in the pharmaceutical and biotech sectors. My journey began at Novartis, where I discovered my talent for systematically identifying and developing key opinion leaders across academic medical centers. Since then, I have expanded my expertise across rare disease, oncology, and neurology markets, ensuring that innovative therapies successfully navigate the complexities of market entry and achieve rapid adoption. I have architected high-impact market development strategies throughout my career, ensuring alignment between scientific credibility and commercial objectives. Whether spearheading % product growth for Darzalex, securing critical EMR placements in limited distribution channels, or leading a task force that increased revenue % within 4 months, my focus remains on delivering measurable commercial impact. At SOBI NA/CTI, I created a comprehensive mapping of strategic networks that streamlined stakeholder identification. At Celgene, I built innovative speaker bureau initiatives that enhanced KOL access across departments. Colleagues recognize me as a strategic, clinically astute leader who fosters collaboration and uncovers new market opportunities. KOLs appreciate my consultative approach, which balances scientific rigor with practical applications. Key strengths include KOL Identification & Development, Rare Disease Market Navigation, Clinical Education, Disease State Positioning, and Biotech Startup Acceleration: Generated $. in revenue at SOBI NA/CTI, achieving + for 3 consecutive years. Drove % growth for Darzalex and % for Imbruvica at Janssen through sophisticated KOL engagement strategies. Founded and led MSK Task Force at Celgene that increased revenue % within 4 months. I believe in the power of collaborative "," leadership to transform scientific innovation into commercial success. My approach is rooted in strategic relationship building, clinical acumen, and market insight, ensuring novel therapies find their optimal position in complex treatment landscapes. I am actively exploring opportunities where I can leverage my expertise to drive commercial success for biotech startups and companies with disease-modifying therapies.#opentonetworking #marketdevelopment #raredisease #biotech #keyaccountmanager #opentowork #SalesExcellence